Neon Therapeutics, Inc. Made Big Gain
Wed, Dec 11, 2019 at 05:30 PM
Neon Therapeutics, Inc. (NTGN:NASDAQ) soared at $1.36, representing a gain of 23.6%. The stock appeared on our News Catalysts scanner on Fri 22 Nov 19 at 12:16 PM in the 'RECOMMENDATION' category. From Tue 19 Nov 19, the stock recorded 21.43% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Neon Therapeutics, Inc. (NTGN:NASDAQ)
Neon Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.
Top 10 Gainers:
- CTI Industries Corporation (CTIB:NASDAQ), 150.81%
- DPW Holdings, Inc. (DPW:NYSEMKT), 82.39%
- Forward Pharma A/S (FWP:NASDAQ), 69.91%
- Camber Energy, Inc. (CEI:NYSEMKT), 69.42%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 40.72%
- Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ), 37.98%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 31.4%
- Immunic, Inc. (IMUX:NASDAQ), 24.62%
- Centogene N.V. (CNTG:NASDAQ), 23.76%
- Neon Therapeutics, Inc. (NTGN:NASDAQ), 23.64%